Crisis in Congo: The Search for an Effective Ebola Vaccine
Since it was first identified in 1976, Ebola has affected several African countries, most recently the Democratic Republic of Congo.
Ebola
Ebola
Featured Article
Latest News
Harnessing Key Elements of the Ebola Virus in Animal Models of Glioblastoma
A glycoprotein in Ebola called the mucin-like domain may be of interest in the development of an oncolytic for brain cancer.
Ebola Virus RNA May Persist in Semen, Breast Milk for Longer Than Anticipated
Data from a large sample of Ebola survivors confirmed the persistence of Ebola viral RNA in semen for up to 6 months.
First Ebola Vaccine Receives FDA Approval
The FDA has approved Ervebo (Ebola Zaire vaccine, live) for the prevention of disease caused by Zaire ebolavirus in individuals ≥18 years of age.
First Ebola Vaccine Approved by European Commission
The world’s first Ebola vaccine has been approved by the European Commission, and it was quickly prequalified by the World Health Organization.
Two New Medications May Cure Ebola
New drugs cured two Ebola patients in Congo, showing that people can recover from the highly lethal disease if it is diagnosed and treated early.
First Ebola Transmission in Congo City of Goma Reported
The first transmission of the Ebola virus in Congo’s major city of Goma was announced.
Congo Officials: First Ebola Case Confirmed in City of Goma
The first case of Ebola in the city of Goma has been confirmed, Democratic Republic of Congo officials said Sunday.
WHO: Congo Ebola Outbreak Still Not Global Emergency
Agency says outbreak is an ‘extraordinary event’ of deep concern but not a global emergency
CDC Opens Emergency Operations Center for Congo Ebola Outbreak
The United States is stepping up its response to a historic outbreak of Ebola in two African nations.
Evaluating Survival Management of Patients With Ebola Virus Disease
A recent study examining Ebola virus disease survival and intravenous fluid administration brings to light broader knowledge gaps about survival management that should be studied further.
Monoclonal Antibody mAb114 Targeting Ebola Is Safe and Well-Tolerated
A single monoclonal antibody, mAb114, targeting the receptor-binding domain of Ebola virus glycoprotein showed linear pharmacokinetics and was easily and rapidly infused.
Congo Ebola Outbreak Claims Nearly 100 Children’s Lives
The ongoing Ebola outbreak in the Democratic Republic of Congo has claimed the lives of nearly 100 children, and the number of cases are on the rise.
U.S. Doctor Released From Omaha Hospital After Ebola Monitoring
Patient completed required 21-day monitoring period and did not develop any symptoms.
US Doctor Monitored for Ebola Exposure in Nebraska Hospital
So far, the American has not shown any symptoms of infection from the virus.
Three New Ebola Vaccines Demonstrate Persistent Immune Response
The immunogenicity generated by 3 experimental Ebola vaccines appears to be long-lasting, as it has persisted for at least 2.5 years.
Dual Injection Ebola Virus Glycoprotein Synthetic DNA Vaccines Are Protective
A simple intradermalanti-Ebola DNA vaccine may generate strong immunogenicity and induce long-term immune responses in nonhuman primates.
Newborns Infected With Ebola in Congo Outbreak
Ebola infections in newborns are being reported in the current outbreak of the deadly disease in Congo.
Ebola Outbreak Worst in Congo’s History
The current Ebola outbreak in Congo is the worst in the country’s recorded history.
Quick New Ebola Test Approved by FDA
A fast, single-use fingerstick test for infection with the Ebola virus has been approved by the FDA.
CDC Director Says Congo Ebola Outbreak May Be Uncontainable
It may not be possible to bring the Ebola outbreak in Congo under control, and the deadly disease may become entrenched in the northeastern part of the country.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Ebola
